TCL Archive New Technology May Enable Therapy Tailored To Patient’s Predicted Response April 26, 2002
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: Eight Minority CCP Awards Confirmed, Four More Coming; General Motors Winners Named June 15, 1990